Medical Facilities(TSE:DR)
CA$17.10-0.08 (-0.47%)
TSE:DR
Medical Facilities financials statements
CA$17.10
At close:-0.08 (-0.47%)
Want to see TSE:DR full AI Analyst Report?
Medical Facilities (DR) Ratios
98 Followers
Medical Facilities Ratios
TSE:DR's free cash flow for Q3 2026 was $15.33M. For the 2026 fiscal year, TSE:DR's free cash flow was decreased by $-1.40M and operating cash flow was $16.72M. See a summary of the company’s cash flow.
| Ratios | Dec 25 | Dec 24 | Dec 23 | Dec 22 | Dec 21 |
|---|---|---|---|---|---|
| Liquidity Ratios | |||||
| Current Ratio | 1.79 | 1.86 | 1.24 | 1.37 | 1.69 |
| Quick Ratio | 1.70 | 1.79 | 1.13 | 1.27 | 1.57 |
| Cash Ratio | 0.63 | 1.22 | 0.29 | 0.40 | 0.69 |
| Solvency Ratio | 0.21 | 0.47 | 0.17 | 0.06 | 0.15 |
| Operating Cash Flow Ratio | 0.67 | 0.94 | 0.88 | 0.66 | 0.86 |
| Short-Term Operating Cash Flow Coverage | 13.73 | 8.02 | 5.07 | 5.86 | 14.29 |
| Net Current Asset Value | $ -49.43M | $ -33.51M | $ -133.82M | $ -143.77M | $ -124.92M |
| Leverage Ratios | |||||
| Debt-to-Assets Ratio | 0.22 | 0.21 | 0.33 | 0.38 | 0.32 |
| Debt-to-Equity Ratio | 0.78 | 0.61 | 1.36 | 1.81 | 1.10 |
| Debt-to-Capital Ratio | 0.44 | 0.38 | 0.58 | 0.64 | 0.52 |
| Long-Term Debt-to-Capital Ratio | 0.26 | 0.16 | 0.39 | 0.49 | 0.37 |
| Financial Leverage Ratio | 3.61 | 2.84 | 4.13 | 4.77 | 3.50 |
| Debt Service Coverage Ratio | 8.37 | 3.93 | 2.08 | 2.03 | 3.19 |
| Interest Coverage Ratio | 13.23 | 5.10 | 4.07 | 2.71 | 3.01 |
| Debt to Market Cap | 0.13 | 0.17 | 0.40 | 0.49 | 0.35 |
| Interest Debt Per Share | 3.20 | 4.65 | 5.26 | 5.31 | 5.36 |
| Net Debt to EBITDA | 0.24 | -0.42 | 1.28 | 2.11 | 0.77 |
| Profitability Margins | |||||
| Gross Profit Margin | 37.97% | 66.32% | 66.58% | 66.10% | 67.38% |
| EBIT Margin | 18.36% | 19.06% | 11.42% | 7.16% | 19.22% |
| EBITDA Margin | 24.41% | 24.91% | 16.26% | 12.05% | 25.94% |
| Operating Profit Margin | 18.36% | 18.59% | 15.06% | 8.23% | 19.41% |
| Pretax Profit Margin | 15.58% | 15.42% | 11.74% | 4.12% | 12.77% |
| Net Profit Margin | 8.15% | 22.17% | 4.15% | -1.04% | 3.89% |
| Continuous Operations Profit Margin | 13.62% | 17.13% | 9.87% | 2.90% | 11.66% |
| Net Income Per EBT | 52.34% | 143.79% | 35.36% | -25.17% | 30.46% |
| EBT Per EBIT | 84.85% | 82.92% | 77.97% | 50.10% | 65.78% |
| Return on Assets (ROA) | 7.75% | 21.22% | 5.21% | -1.17% | 3.47% |
| Return on Equity (ROE) | 27.99% | 60.23% | 21.52% | -5.57% | 12.15% |
| Return on Capital Employed (ROCE) | 23.31% | 23.95% | 24.68% | 12.01% | 21.55% |
| Return on Invested Capital (ROIC) | 19.50% | 22.28% | 19.10% | 7.89% | 18.91% |
| Return on Tangible Assets | 10.96% | 29.58% | 8.30% | -1.80% | 5.23% |
| Earnings Yield | 9.36% | 36.62% | 10.78% | -2.53% | 6.74% |
| Efficiency Ratios | |||||
| Receivables Turnover | 7.34 | 6.50 | 6.40 | 6.57 | 5.91 |
| Payables Turnover | 10.46 | 6.59 | 6.43 | 5.45 | 5.43 |
| Inventory Turnover | 27.55 | 19.23 | 16.53 | 15.60 | 12.21 |
| Fixed Asset Turnover | 3.70 | 3.99 | 3.71 | 3.40 | 3.00 |
| Asset Turnover | 0.95 | 0.96 | 1.26 | 1.12 | 0.89 |
| Working Capital Turnover Ratio | 3.97 | 6.89 | 17.04 | 9.09 | 7.53 |
| Cash Conversion Cycle | 28.10 | 19.78 | 22.37 | 12.01 | 24.45 |
| Days of Sales Outstanding | 49.76 | 56.19 | 57.04 | 55.56 | 61.76 |
| Days of Inventory Outstanding | 13.25 | 18.98 | 22.08 | 23.40 | 29.89 |
| Days of Payables Outstanding | 34.91 | 55.38 | 56.75 | 66.96 | 67.20 |
| Operating Cycle | 63.01 | 75.16 | 79.12 | 78.96 | 91.65 |
| Cash Flow Ratios | |||||
| Operating Cash Flow Per Share | 2.36 | 4.50 | 2.87 | 1.94 | 2.43 |
| Free Cash Flow Per Share | 2.10 | 4.12 | 2.24 | 1.71 | 2.16 |
| Dividend Paid and CapEx Coverage Ratio | 4.53 | 6.32 | 3.29 | 4.01 | 4.93 |
| Capital Expenditure Coverage Ratio | 9.26 | 11.78 | 4.53 | 8.49 | 8.98 |
| Operating Cash Flow Coverage Ratio | 0.78 | 1.13 | 0.62 | 0.40 | 0.54 |
| Operating Cash Flow to Sales Ratio | 0.18 | 0.25 | 0.16 | 0.13 | 0.19 |
| Free Cash Flow Yield | 18.21% | 37.98% | 33.02% | 28.88% | 29.25% |
| Valuation Ratios | |||||
| Price-to-Earnings (P/E) Ratio | 10.60 | 2.73 | 9.27 | -39.54 | 14.83 |
| Price-to-Sales (P/S) Ratio | 0.87 | 0.61 | 0.39 | 0.41 | 0.58 |
| Price-to-Book (P/B) Ratio | 2.99 | 1.64 | 2.00 | 2.20 | 1.80 |
| Price-to-Free Cash Flow (P/FCF) Ratio | 5.49 | 2.63 | 3.03 | 3.46 | 3.42 |
| Price-to-Operating Cash Flow Ratio | 4.90 | 2.41 | 2.36 | 3.06 | 3.04 |
| Price-to-Earnings Growth (PEG) Ratio | 1.82 | 0.07 | 0.13 | 0.55 | 0.59 |
| Enterprise Value Multiple | 3.81 | 2.01 | 3.65 | 5.52 | 3.00 |
| Enterprise Value | 240.50M | 166.12M | 264.30M | 282.21M | 309.70M |
| EV to EBITDA | 3.81 | 2.01 | 3.65 | 5.52 | 3.00 |
| EV to Sales | 0.93 | 0.50 | 0.59 | 0.66 | 0.78 |
| EV to Free Cash Flow | 5.87 | 2.18 | 4.66 | 5.61 | 4.61 |
| EV to Operating Cash Flow | 5.23 | 1.99 | 3.63 | 4.95 | 4.09 |
| Tangible Book Value Per Share | 1.06 | 2.68 | -0.54 | -0.65 | 0.73 |
| Shareholders’ Equity Per Share | 3.87 | 6.60 | 3.39 | 2.69 | 4.10 |
| Tax and Other Ratios | |||||
| Effective Tax Rate | 0.13 | -0.11 | 0.16 | 0.30 | 0.09 |
| Revenue Per Share | 13.28 | 17.92 | 17.58 | 14.46 | 12.82 |
| Net Income Per Share | 1.08 | 3.97 | 0.73 | -0.15 | 0.50 |
| Tax Burden | 0.52 | 1.44 | 0.35 | -0.25 | 0.30 |
| Interest Burden | 0.85 | 0.81 | 1.03 | 0.58 | 0.66 |
| Research & Development to Revenue | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| SG&A to Revenue | 0.46 | 0.46 | 0.34 | 0.47 | 0.45 |
| Stock-Based Compensation to Revenue | 0.00 | -0.00 | -0.00 | -0.00 | 0.00 |
| Income Quality | 2.18 | 0.79 | 1.65 | 4.64 | 1.63 |
Currency in USD

